您的购物车当前为空
别名 PLK1 Inhibitor
MLN0905 (PLK1 Inhibitor) 是一种 PLK1的有效抑制剂,IC50值为 2 nM。


为众多的药物研发团队赋能,
让新药发现更简单!
MLN0905 (PLK1 Inhibitor) 是一种 PLK1的有效抑制剂,IC50值为 2 nM。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 419 | In stock | |
| 5 mg | ¥ 987 | In stock | |
| 10 mg | ¥ 1,490 | In stock | |
| 25 mg | ¥ 2,690 | In stock | |
| 50 mg | ¥ 3,890 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 1,090 | In stock |
MLN0905 相关产品
| 产品描述 | MLN0905 (PLK1 Inhibitor) is an effective PLK1 inhibitor(IC50=2 nM). |
| 靶点活性 | PLK1:2 nM |
| 体外活性 | 在携带HT-29异种移植物的裸鼠中,口服MLN0905(6.25 mg / Kg-50 mg / Kg)能够在治疗48小时后,表现剂量依赖的药效反应.在携带OCI LY-19-Luc肿瘤的小鼠中,口服MLN0905(3.12 mg / Kg-6.25 mg / Kg)在治疗后8小时表现药效反应. |
| 体内活性 | MLN0905是PLK1抑制剂(IC50=2 nM)。 LN0905抑制细胞有丝分裂(EC50=9 nM)。在HT-29细胞中(LD50=22 nM),MLN0905能够抑制细胞增殖。在一组淋巴瘤细胞中(IC50=3 - 24 nM),MLN0905能够抑制细胞活力。 |
| 激酶实验 | PLK1 Flash Plate Assay: The human PLK1 enzymatic reaction totaling 30μL contained 50 mM Tris-HCl (pH 8.0), 10 mM MgCl2, 0.02% BSA, 10% glycerol, 1 mM DTT, 100 mM NaCl, 3.3% DMSO, 8 μM ATP, 0.2μCi [γ- 33 P]-ATP, 4 μM peptide substrate (Biotin-AHX-LDETGHLDSSGLQEVHLA-CONH2), and 10 nM recombinant human PLK1[2–369]T210D. The enzymatic reaction mixture, with or without PLK inhibitors, is incubated for 2.5 h at 30℃before termination with 20μL of 150 mM EDTA. Then 25μL of the stopped enzyme reaction mixture is transferred to a 384-well streptavidin coated Image FlashPlate and incubated at room temperature for 3 h. The Image Flash Plate wells are washed three times with 0.02% Tween-20 and then read on the Perkin-Elmer Viewlux. |
| 别名 | PLK1 Inhibitor |
| 分子量 | 486.56 |
| 分子式 | C24H25F3N6S |
| CAS No. | 1228960-69-7 |
| Smiles | CN(C)CCCc1cnc(C)c(Nc2ncc3CC(=S)Nc4cc(ccc4-c3n2)C(F)(F)F)c1 |
| 密度 | 1.37 g/cm3 at 20℃ |
| 颜色 | Yellow |
| 物理性状 | Solid |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | Ethanol: < 1 mg/mL (insoluble or slightly soluble) DMSO: 90 mg/mL (184.97 mM), Sonication is recommended. H2O: < 1 mg/mL (insoluble or slightly soluble) | |||||||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 3.3 mg/mL (6.78 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容